CardiovascularTOPICALStandard
NYSTATIN
NYSTATIN
Standard Dose
100,000 UNITS/GM
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview NYSTATIN is listed in Drugs@FDA under application 213826 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient NYSTATIN Form and strength OINTMENT;TOPICAL - 100,000 UNITS/GM Sponsor MACLEODS PHARMS LTD Submission history Latest submission status date: 2021-01-14 00:00:00.
Structured Monograph
Clinical summary
Approval overview NYSTATIN is listed in Drugs@FDA under application 213826 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient NYSTATIN Form and strength OINTMENT;TOPICAL - 100,000 UNITS/GM Sponsor MACLEODS PHARMS LTD Submission history Latest submission status date: 2021-01-14 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.